Journal of Nanobiotechnology · 2021 · 45 citations · 45 references
Life SciencesBiomedical EngineeringMicrobiologyBiomaterialsDrug DeliveryNanobiotechnologyAntibacterial AgentsAntimicrobial BiomaterialsEndotoxin RemovalNanomaterials For Drug DeliveryNanomedicineNanostructured BiomaterialsAntibacterial BiomaterialsAntibacterial CoatingsAntibacterial MaterialsAntibacterial NanomaterialsAntibacterial Photothermal TherapyAntibacterial PropertiesAntimicrobial MicrospheresMesoporous Materials
Serious infection caused by drug-resistant gram-negative bacteria and their secreted toxins (e.g., lipopolysaccharide) is a serious threat to human health. Thus, treatment strategies that efficiently kill bacteria and reducing the impact of their toxins simultaneously are urgently required. Herein, a novel antibacterial platform composed of a mesoporous copper silicate microsphere (CSO) core and a platelet membrane (PM) shell was prepared (CSO@PM). CSO@PM specifically targets bacteria owing to formyl peptide receptors on the PM and, combined with photothermal therapy (PTT), exhibits highly effective bacter icidal activity. Importantly, CSO@PM can adsorb lipopolysaccharide secreted by gram-negative bacteria, resulting in inflammation reduction. Thus, CSO@PM stimulates re-epithelialization and granulation-tissue formation, promoting wound healing. Moreover, this antibacterial platform exhibits no obvious toxicity at all the test concentrations in vitro and in vivo. Thus, CSO@PM exhibits a robust antibacterial effect and a strong toxin-adsorption capacity, facilitating the clinical treatment of many bacterial infections and the development of next-generation antibacterial nanoagents.
45
A biomimetic nanosponge that absorbs pore-forming toxins
Che‐Ming Jack Hu, Ronnie H. Fang, Jonathan A. Copp et al. · Nature Nanotechnology · 2013 · 744 citations · Full text
Platelet Membrane‐Camouflaged Magnetic Nanoparticles for Ferroptosis‐Enhanced Cancer Immunotherapy
Qin Jiang, Kuang Wang, Xingyu Zhang et al. · Small · 2020 · 430 citations
Life Sciences, Immunology, Oncology +17